1-20 of 24
Authors: Irina Alimova
Sort by
Journal Article
ATRT-07. PRC1/BMI1 ACTIVITY ALTERS CHROMATIN ACCESSIBILITY TO REGULATE DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS Open Access
Irina Alimova and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.007
Published: 18 June 2024
Journal Article
EPEN-23. TARGETING TRISOMY MDM4 INDUCES CELL DEATH IN 1Q+ PFA EPENDYMOMA THROUGH REACTIVATION OF THE P53 PATHWAY Open Access
Annaliese J Calzadilla and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.225
Published: 18 June 2024
Journal Article
ATRT-01. PARP INHIBITION AS A THERAPEUTIC TARGET IN ATRT Open Access
Irina Alimova and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i1, https://doi.org/10.1093/neuonc/noad073.001
Published: 12 June 2023
Journal Article
ATRT-23. SIRT2 cooperates with SMARCB1 to induce a differentiation block in ATRT Open Access
Irina Alimova and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i8, https://doi.org/10.1093/neuonc/noac079.022
Published: 03 June 2022
Journal Article
A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy Free
Dong Wang and others
Neuro-Oncology, Volume 24, Issue 3, March 2022, Pages 414–426, https://doi.org/10.1093/neuonc/noab207
Published: 03 September 2021
Journal Article
ATRT-08. TARGETING THE TP53-MDM2 ENHANCES RADIATION SENSITIVITY IN ATRT Open Access
Irina Alimova and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Pages i2–i3, https://doi.org/10.1093/neuonc/noab090.007
Published: 01 June 2021
Journal Article
EMBR-30. A NOVEL PLK1 INHIBITOR ONVANSERTIB EFFECTIVELY SENSITIZES GROUP 3 MEDULLOBLASTOMA TO RADIOTHERAPY Open Access
Dong Wang and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i12, https://doi.org/10.1093/neuonc/noab090.047
Published: 01 June 2021
Journal Article
IMG-17. RADIOMICS CHARACTERIZATION OF FOUR PEDIATRIC BRAIN TUMOR SUBTYPES IN PDX MOUSE MODELS Open Access
Natalie Serkova and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii358, https://doi.org/10.1093/neuonc/noaa222.352
Published: 04 December 2020
Journal Article
ATRT-06. SMARCB1 LOSS DRIVEN NON-CANONICAL PRC1 ACTIVITY REGULATES DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS (ATRT) Open Access
Irina Alimova and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii276–iii277, https://doi.org/10.1093/neuonc/noaa222.006
Published: 04 December 2020
Journal Article
DIPG-73. SENESCENCE ASSOCIATED SECRETORY PHENOTYPE AS A MECHANISM OF RESISTANCE AND THERAPEUTIC VULNERABILITY IN BMI1 INHIBITOR TREATED DIPG Open Access
Ilango Balakrishnan and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii301, https://doi.org/10.1093/neuonc/noaa222.115
Published: 04 December 2020
Journal Article
ATRT-05. PRC1 IS AN ESSENTIAL DEPENDENCY AND THERAPEUTIC TARGET IN SMARCB1 DEFICIENT ATYPICAL TERATOID RHABDOID TUMORS Free
Irina Alimova and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Pages ii63–ii64, https://doi.org/10.1093/neuonc/noz036.004
Published: 23 April 2019
Journal Article
ATRT-12. TARGETING SIRT2 IN SMARCB1 DEFICIENT ATRT Free
Irina Alimova and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i29–i30, https://doi.org/10.1093/neuonc/noy059.011
Published: 22 June 2018
Journal Article
DIPG-55. TARGETING SENESCENT CELLS WITH ABT-263 ENHANCES CELL DEATH INDUCED BY BMI1 INHIBITION AND IONIZING RADIATION IN DIPG Free
Ilango Balakrishnan and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i60, https://doi.org/10.1093/neuonc/noy059.148
Published: 22 June 2018
Journal Article
EPEN-20. IDENTIFICATION AND INVESTIGATION OF A NOVEL EPIGENETIC MODULATOR IN POSTERIOR FOSSA EPENDYMOMA, SIRT2 Free
Davis Witt and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i77, https://doi.org/10.1093/neuonc/noy059.221
Published: 22 June 2018
Journal Article
ATRT-18. VALIDATION OF PROTEASOME INHIBITION AS A THERAPEUTIC TARGET IN ATYPICAL TERATOID/RHABDOID TUMORS Free
Andrew Morin and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i31, https://doi.org/10.1093/neuonc/noy059.016
Published: 22 June 2018
Journal Article
MEDU-33. PLK1 INHIBITION IN COMBINATION WITH STANDARD THERAPIES FOR MYC-DRIVEN MEDULLOBLASTOMA Free
Ilango Balakrishnan and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv44, https://doi.org/10.1093/neuonc/nox083.183
Published: 31 May 2017
Journal Article
ATRT-07. AN EPIGENOME DIRECTED FUNCTIONAL GENOMIC SCREEN IDENTIFIES SIRT2 AS A SYNTHETIC LETHAL TARGET IN SMARCB1 DEFICIENT ATRT Free
Irina Alimova and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv2, https://doi.org/10.1093/neuonc/nox083.006
Published: 31 May 2017
Journal Article
AT-07PLK1 AS A THERAPEUTIC TARGET IN ATRT Free
Irina Alimova and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii2, https://doi.org/10.1093/neuonc/now065.06
Published: 30 May 2016
Journal Article
HG-78SYNTHETIC LETHAL EPIGENETIC INTERACTIONS IN K27M MUTATED DIPG Free
Sujatha Venkataraman and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii66, https://doi.org/10.1093/neuonc/now073.74
Published: 30 May 2016
Journal Article
AT-04TARGETING Myc DRIVEN TRANSCRIPTIONAL OUTPUT IN ATYPICAL TERATOID RHABDOID TUMOR
Get access
Irina Alimova and others
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Pages iii1–iii2, https://doi.org/10.1093/neuonc/nov061.4
Published: 21 April 2015
Advertisement
Advertisement